Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2010, Vol. 4 Issue (1) : 36-42    https://doi.org/10.1007/s11684-010-0020-y
Research articles
Molecular mechanisms and therapeutic strategies of vulnerable atherosclerotic plaques
Wen-Qiang CHEN MD,Yun ZHANG MD, PhD, FACC,
The Key Laboratory of Cardiovascular Remodeling and Function Research, Ministry of Education and Ministry of Health, Shandong University Qilu Hospital, Jinan 250012, China;
 Download: PDF(107 KB)  
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract Vulnerable atherosclerotic plaque rupture leading to thrombosis is the major cause of acute coronary syndrome (ACS). Studies on the pathophysiologic mechanism of both ACS and plaque stabilizing treatment are driving the development of animal models of vulnerable plaque. In our laboratory, we established animal models of plaque rupture and thrombosis in rabbits and mice that are similar to human plaque rupture. Potential mechanisms involved in plaque vulnerability were studied from the inflammation-immunity, proliferation-apoptosis, oxidative stress and biomechanics aspects. Imaging markers and biomarkers were used to detect vulnerable plaques, including high frequency duplex ultrasound, intravascular ultrasound (IVUS), intravascular ultrasound elastography, magnetic resonance imaging (MRI) and inflammatory markers. Effective gene and drug strategies to treat vulnerable plaques were explored.
Keywords vulnerable plaque      animal models      mechani-sm      detection      treatment      
Issue Date: 05 March 2010
 Cite this article:   
Wen-Qiang CHEN MD,PhD,Yun ZHANG MD, et al. Molecular mechanisms and therapeutic strategies of vulnerable atherosclerotic plaques[J]. Front. Med., 2010, 4(1): 36-42.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-010-0020-y
https://academic.hep.com.cn/fmd/EN/Y2010/V4/I1/36
Ni M, Chen W Q, Zhang Y. Animal models and potential mechanismsof plaque destabilization and disruption. Heart, 2009, 95(17): 1393–1398

doi: 10.1136/hrt.2008.143461
Chen W Q, Zhang Y, Zhang M, Yin Y, Zhu Y F. Establishing an animal modelof unstable atherosclerotic plaques. ChinMed J (Engl), 2004, 117(9): 1293–1298
Chen W Q, Zhang L, Liu Y F, Chen L, Ji X P, Zhang M, Zhao Y X, Yao G H, Zhang C, Wang X L, Zhang Y. Prediction of atherosclerotic plaque ruptures with high-frequencyultrasound imaging and serum inflammatory markers. Am J Physiol Heart Circ Physiol, 2007, 293(5): H2836–H2844

doi: 10.1152/ajpheart.00472.2007
Lin H L, Xu X S, Lu H X, Zhang L, Li C J, Tang M X, Sun H W, Liu Y, Zhang Y. Pathologicalmechanisms and dose dependency of erythrocyte-induced vulnerabilityof atherosclerotic plaques. J Mol Cel Cardiol, 2007, 43(3): 272–280

doi: 10.1016/j.yjmcc.2007.05.023
Ni M, Wang Y, Zhang M, Zhang P F, Ding S F, Liu C X, Liu X L, Zhao Y X, Zhang Y. Atheroscleroticplaque disruption induced by stress and lipopolysaccharide in apolipoproteinE knockout mice. Am J Physiol Heart CircPhysiol, 2009, 296(5): H1598–1606

doi: 10.1152/ajpheart.01202.2008
Ni M, Zhang M, Ding S F, Chen W Q, Zhang Y. Micro-ultrasound imagingassessment of carotid plaque characteristics in apolipoprotein-Eknockout mice. Atherosclerosis, 2008, 197(1): 64–71

doi: 10.1016/j.atherosclerosis.2007.07.039
Zhang M X, Zhang C, Shen Y H, Wang J, Li X N, Zhang Y, Coselli J, Wang X L. Biogenesis of short intronicrepeat 27 nt small RNA from endothelial nitric oxide synthase gene. J Biol Chem, 2008, 283(21): 14685–14693

doi: 10.1074/jbc.M801933200
Zhang M X, Zhang C, Shen Y H, Wang J, Li X N, Chen L, Zhang Y, Coselli J S, Wang X L. Effect of 27nt small RNA on endothelial nitric oxidesynthase expression. Mol Biol Cell, 2008, 19(9): 3997–4005

doi: 10.1091/mbc.E07-11-1186
Zhong L, Chen W Q, Ji X P, Zhang M, Zhao Y X, Yao G H, Zhang P F, Zhang C, Zhang Y. Dominant-negativemutation of monocyte chemoattractant protein-1 prevents vulnerableplaques from rupture in rabbits independent of serum lipid levels. J Cell Mol Med, 2008, 12(6A): 2362–2371

doi: 10.1111/j.1582-4934.2008.00261.x
Zhang C, Zhang M X, Shen Y H, Burks J K, Zhang Y, Wang J, LeMaire S A, Yoshimura K, Aoki H, Coselli J S, Wang X L. TNF-alpha suppresses prolyl-4-hydroxylasealpha1 expression via the ASK1-JNK-NonO pathway. Arterioscler Thromb Vasc Biol, 2007, 27(8): 1760–1767

doi: 10.1161/ATVBAHA.107.144881
Zhang C, Zhang M, Shen Y, Burks J, Li X, LeMaire S, Yoshimura K, Aoki H, Matsuzaki M, An F, Engler D, Matsunami R, Coselli J, Zhang Y, Wang X. Role of NonO-histoneinteraction in TNFα-suppressed prolyl-4-hydroxylase α1. Biochim Biophys Acta, 2008, 1783(8): 1517–1528

doi: 10.1016/j.bbamcr.2008.03.011
Guo T, Chen W Q, Zhang C, Zhao Y X, Zhang Y. Chymase activity is closelyrelated with plaque vulnerability in a hamster model of atherosclerosis. Atherosclerosis, 2009, 207(1): 59–67

doi: 10.1016/j.atherosclerosis.2009.04.014
Dong B, Zhang C, Feng J, Zhao Y, Li S, Yang Y, Dong Q, Deng B, Zhu L, Yu Q, Liu C, Liu B, Pan C, Song H, Zhang M, Zhang Y. Overexpression of ACE2 enhances plaque stability in arabbit model of atherosclerosis. ArteriosclerThromb Vasc Biol, 2008, 28(7): 1270–1276

doi: 10.1161/ATVBAHA.108.164715
Liu P, Zhang C, Feng J B, Zhao Y X, Wang X P, Yang J M, Zhang M X, Wang X L, Zhang Y. Cross-talkamong smad, MAPK, and integrin signaling pathways enhances adventitialfibroblast functions activated by transforming growth factor {beta}1 and inhibited by Gax. Arterioscler ThrombVasc Biol, 2008, 28(4): 725–731

doi: 10.1161/ATVBAHA.107.159889
Xu X S, Lin H L, Lv H X, Zhang M, Zhang Y. Adventitial lymphatic vessels,an important role in atherosclerosis. MedHypotheses, 2007, 70(1): 1238–1241

doi: 10.1016/j.mehy.2007.04.007
Xu X, Lu H, Lin H, Li X, Ni M, Sun H, Li C, Jiang H, Li F, Zhang M, Zhao Y, Zhang Y. Aortic adventitialangiogenesis and lymphangiogenesis promote intimal inflammation andhyperplasia. Cardiovasc Pathol, 2009, 18(5): 269–278

doi: 10.1016/j.carpath.2008.07.004
Qi L H, Wang Y, Gao F, Zhang C, Ding S F, Ni M, Feng J B, Zhang Y. Enhanced stabilization of atherosclerosisplaques in apolipoprotein E-knockout mice by combinatorial Toll-likereceptor 1 and 2 gene silencing. Hum GeneTher, 2009, 20(7): 739–750

doi: 10.1089/hum.2008.203
Qi L H, Wang Y, Zhang C, Ding S F, Ni M, Feng J B, Zhang Y. Combinatorialinterference of Toll-like receptor 2 and 4 remarkably stabilizes atheroscleroticplaque in apolipoprotein E-knockout mice. J Am Coll Cardiol (Abs), 2009, 53, Suppl: A423
Hu Q, Zhang X J, Liu C X, Wang X P, Zhang Y. PPARγ1-induced caveolin-1enhances cholesterol efflux and attenuates atherosclerosis in apolipoproteinE-deficient mice. J Vasc Res, 2010, 47(1): 69–79

doi: 10.1159/000235927
Hu Q, Zhang X J, Zhang C, Zhao Y X, He H, Liu C X, Feng J B, Jiang H, Yang F L, Zhang C X, Zhang Y. Peroxisome proliferator-activated receptor-γ1 genetherapy attenuates atherosclerosis and stabilizes plaques in apolipoproteinE-deficient mice. Hum Gene Ther, 2008, 19(3): 287–299

doi: 10.1089/hum.2007.0142
Wang W, Liu X, Zhao J, Zhao B, Zhang S, Miao J. A novel butyrolactone derivative inhibited apoptosisand depressed integrin beta4 expression in vascular endothelial cells. Bioorg Med Chem Lett, 2007, 17(2): 482–485

doi: 10.1016/j.bmcl.2006.10.023
Wang W, Liu X, Zhang Y, Zhao J, Zhao B, Zhang S, Miao J. Both senescenceand apoptosis induced by deprivation of growth factors were inhibitedby a novel butyrolactone derivative through depressing integrin beta4in vascular endothelial cells. Endothelium, 2007, 14(6): 325–332

doi: 10.1080/10623320701746206
Meng N, Zhao J, Zhao B, Cheng Y, Wang W, Zhang Y, Zhang S, Miao J. A novel butyrolactone derivative inhibitedsmooth muscle cell migration and proliferation and maintained endothelialcell functions through selectively affecting Na, K-ATPase activityand mitochondria membrane potential during in vitro angiogenesis. J Cell Biochem, 2008, 104(6): 2123–2130

doi: 10.1002/jcb.21769
Chen W Q, Zhong L, Zhang L, Ji X P, Zhang M, Zhao Y X, Zhang C, Zhang Y. Oral rapamycin attenuates inflammationand enhances stability of atherosclerotic plaques in rabbits independentof serum lipid levels. Br J Pharmacol, 2009, 156(6): 941–951

doi: 10.1111/j.1476-5381.2008.00102.x
Sun H W, Li C J, Chen H Q, Lin H L, Lv H X, Zhang Y, Zhang M. Involvementof integrins, MAPK, and NF-kappaB in regulation of the shear stress-inducedMMP-9 expression in endothelial cells. Biochem Biophys Res Commun, 2007, 353(1): 152–158

doi: 10.1016/j.bbrc.2006.12.002
Zhang P F, Su H J, Yao G H, Wu W, Zhang M, Liu C X, Jiang H, Ding S F, Zhang C, Zhao Y X, Zhang Y. Plaque volume compression ratio, a novel biomechanicalindex, is independently associated with ischemic cerebrovascular events. J Hypertens, 2009, 27(2): 348–356
Ding S, Zhang M, Zhao Y, Chen W, Yao G, Zhang C, Zhang P, Zhang Y. The role of carotid plaque vulnerabilityand inflammation in the pathogenesis of acute ischemic stroke. Am J Med Sci, 2008, 336(1): 27–31

doi: 10.1097/MAJ.0b013e31815b60a1
Chen W Q, Zhang M, Ji X P, Ding S F, Zhao Y X, Chen Y G, Zhang C, Zhang Y. Usefulness of high-frequency vascularultrasound imaging and serum inflammatory markers to predict plaquerupture in patients with stable and unstable angina pectoris. Am J Cardiol, 2007, 100(9): 1341–1346

doi: 10.1016/j.amjcard.2007.06.044
Zhang Y. Author Reply. Am J Cardiol, 2008, 101(10): 1519

doi: 10.1016/j.amjcard.2008.02.009
Wang Y, Li L, Tan H W, Yu G S, Ma Z Y, Zhao Y X, Zhang Y. Transcoronaryconcentration gradient of sCD40L and hsCRP in patients with coronaryheart disease. Clin Cardiol, 2007, 30(2): 86–91

doi: 10.1002/clc.26
Chen W Q, Zhong L, Zhang L, Ji X P, Zhao Y X, Zhang C, Jiang H, Wu Y L, Zhang Y. Chinesemedicine tongxinluo significantly lowers serum lipid levels and stabilizesvulnerable plaques in a rabbit model. JEthnopharmacol, 2009, 124(1): 103–110

doi: 10.1016/j.jep.2009.04.009
Zhang L, Wu Y, Jia Z, Zhang Y, Shen H Y, Wang X L. Protective effects of a compound herbal extract (TongXin Luo) on free fatty acid induced endothelial injury: implicationsof antioxidant system. BMC Complement AlternMed, 2008, 8: 39

doi: 10.1186/1472-6882-8-39
[1] Solmaz Ohadian Moghadam, Seyed Ali Momeni. Human microbiome and prostate cancer development: current insights into the prevention and treatment[J]. Front. Med., 2021, 15(1): 11-32.
[2] Shujian Deng, Xin Zhang, Wen Yan, Eric I-Chao Chang, Yubo Fan, Maode Lai, Yan Xu. Deep learning in digital pathology image analysis: a survey[J]. Front. Med., 2020, 14(4): 470-487.
[3] Ke Sheng. Artificial intelligence in radiotherapy: a technological review[J]. Front. Med., 2020, 14(4): 431-449.
[4] Min Zhou, Xinxin Zhang, Jieming Qu. Coronavirus disease 2019 (COVID-19): a clinical update[J]. Front. Med., 2020, 14(2): 126-135.
[5] Tung Huynh, Ke-Qin Hu. Direct acting antiviral-induced dynamic reduction of serum α fetoprotein in hepatitis C patients without hepatocellular carcinoma[J]. Front. Med., 2019, 13(6): 658-666.
[6] Tianyuan Li, Renbing Jia, Xianqun Fan. Classification and treatment of orbital venous malformations: an updated review[J]. Front. Med., 2019, 13(5): 547-555.
[7] Jing Yue, Bo Zhang, Mingyue Wang, Junning Yao, Yifan Zhou, Ding Ma, Lei Jin. Effect of antitubercular treatment on the pregnancy outcomes and prognoses of patients with genital tuberculosis[J]. Front. Med., 2019, 13(1): 121-125.
[8] Minhong Shen, Yibin Kang. Complex interplay between tumor microenvironment and cancer therapy[J]. Front. Med., 2018, 12(4): 426-439.
[9] Hanjiang Lai, Chen Huang, Jian Cai, Julian Ye, Jun She, Yi Zheng, Liqian Wang, Yelin Wei, Weijia Fang, Xianjun Wang, Yi-Wei Tang, Yun Luo, Dazhi Jin. Simultaneous detection and characterization of toxigenic Clostridium difficile directly from clinical stool specimens[J]. Front. Med., 2018, 12(2): 196-205.
[10] Kuo Yang, Runshun Zhang, Liyun He, Yubing Li, Wenwen Liu, Changhe Yu, Yanhong Zhang, Xinlong Li, Yan Liu, Weiming Xu, Xuezhong Zhou, Baoyan Liu. Multistage analysis method for detection of effective herb prescription from clinical data[J]. Front. Med., 2018, 12(2): 206-217.
[11] Hongbing Shen. Low-dose CT for lung cancer screening: opportunities and challenges[J]. Front. Med., 2018, 12(1): 116-121.
[12] Zongming Zhang, Zhuo Liu, Limin Liu, Mengmeng Song, Chong Zhang, Hongwei Yu, Baijiang Wan, Mingwen Zhu, Zixu Liu, Hai Deng, Haiming Yuan, Haiyan Yang, Wenping Wei, Yue Zhao. Strategies of minimally invasive treatment for intrahepatic and extrahepatic bile duct stones[J]. Front. Med., 2017, 11(4): 576-589.
[13] Yan Ma, Albert C. Yang, Ying Duan, Ming Dong, Albert S. Yeung. Quality and readability of online information resources on insomnia[J]. Front. Med., 2017, 11(3): 423-431.
[14] Jing Zhang,Shan Gao,Zhongping Duan,Ke-Qin Hu. Overview on acute-on-chronic liver failure[J]. Front. Med., 2016, 10(1): 1-17.
[15] Jonathan Skupsky,Ke-Qin Hu. Current hepatitis B treatment guidelines and future research directions[J]. Front. Med., 2014, 8(2): 145-157.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed